26/02/2026
Coffee consumption is linked to reduced mortality from chronic liver disease, primarily through its **antifibrotic**, **antioxidant**, and **anti-inflammatory** effects, along with improvements in metabolic health.
Here are the key mechanisms:
- **Antifibrotic action** — Caffeine blocks adenosine receptors (particularly A2A) on activated hepatic stellate cells, the main drivers of liver fibrosis. This inhibition reduces the release of profibrotic factors like connective tissue growth factor (CTGF) and collagen production, thereby slowing the development and progression of fibrosis toward cirrhosis.
- **Antioxidant protection** — Coffee boosts glutathione levels, a critical antioxidant that helps the liver detoxify reactive oxygen species and harmful substances. Additionally, diterpenes such as kahweol and cafestol upregulate phase II detoxification enzymes (e.g., glutathione S-transferase, or GST), enhancing the neutralization of potential carcinogens and reducing oxidative stress in hepatocytes.
- **Anti-inflammatory effects** — Polyphenols in coffee, especially chlorogenic acid (CGA), inhibit proinflammatory signaling pathways. This lowers production of damaging cytokines and mediators that contribute to ongoing liver injury and chronic inflammation.
- **Metabolic benefits** — Coffee improves insulin sensitivity, reduces hepatic fat accumulation (a major factor in non-alcoholic fatty liver disease, or NAFLD), and promotes autophagy — the body's process for clearing damaged cellular components — helping prevent steatosis and related progression.
- **Clinical markers** — Regular coffee drinkers typically exhibit lower serum levels of liver enzymes such as ALT, AST, and GGT, which are established indicators of hepatocyte damage, inflammation, and liver stress.
These protective effects are supported by epidemiological data showing dose-dependent reductions in chronic liver disease incidence, fibrosis progression, cirrhosis risk, and liver-related mortality among coffee consumers (often most pronounced at ≥2–3 cups/day).
Key references (PMIDs): 37781708, 24464631, 28596816, 25305507.